Effect of chromium supplementation in treatment of coronary heart disease
Phase 3
- Conditions
- Coronary Heart Disease.Chronic ischemic heart disease, unspecifiedI25.9
- Registration Number
- IRCT20170513033941N30
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Inclusion Criteria: Subjects aged 40-85 years; diagnosed with type 2 diabetes and coronary heart disease.
Exclusion Criteria
Exclusion Criteria: Consuming chromium three months prior to the intervention
Taking antioxidant and/or anti-inflammatory supplements such as vitamin E, vitamin C and omega-3 fatty acids
Change in type and dosage of antidiabetic and antilipidemic agents
Having an acute myocardial infarction, a cardiac surgery in the past three months
Renal or hepatic failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.
- Secondary Outcome Measures
Name Time Method